Skip to main content

Day: May 4, 2022

Notification of transactions by members of the board and management

Company announcement no 10-2022 Søborg May 4, 2022 Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them in Konsolidator A/S On April 28, 2022 Konsolidator A/S issued new shares in a directed issue and a board member exercised warrants according to company announcement no 9-2022. The share issue and warrants exercise gave Konsolidator A/S proceeds of DKK 4 million. In accordance with the Market Abuse Regulation, Konsolidator must notify Finanstilsynet and publicly disclose transactions made by persons discharging managerial responsibilities and persons closely associated with them on trading of Konsolidator shares. Konsolidator A/S hereby notify and submit the following transaction of shares in Konsolidator: Name: Cecilia HulténPosition: Member of the boardName...

Continue reading

Strong growth in Q1 – record first quarter revenue

HighlightsStrong 21% organic growth in Q1 2022 – equal to 18% vs Q1 2019 Execution of the Phoenix strategy is progressing as planned with Q1 revenue growth in all product platforms Moments continue to deliver strong results driven by the base portfolio and supported by new products such as the Padlock concept – another innovation within the Moments platform Collabs were very strong supported by a successful Marvel launch in February Efforts to establish new platforms continue. Pandora ME up 132% vs Q1 2021 and reached 3% share of business. Getting ready for next step in the global sequential roll-out of Brilliance Broad based organic growth across key markets vs 2019 – China continue to be a headwind  US grew 7% (62% vs Q1 2019) – strategy on plan with acquisition of 32 franchise stores mainly located on the West coast of...

Continue reading

Interim Report Q1 2022

The Interim Report for the 1st Quarter 2022 for A.P. Møller – Mærsk A/S is hereby enclosed. CEO of A.P. Møller – Mærsk A/S, Søren Skou, states: “In Q1 we delivered the best earnings quarter ever in A.P. Moller – Maersk with growth across Ocean, Logistics and Terminals. The increased earnings are driven by freight rates and by contracts being signed at higher levels. While global supply chains remain under significant pressure, we continue to demonstrate superior ability to help customers overcome logistic challenges. In Logistics, we enjoyed strong demand for products and solutions across our portfolio leading to the 5th quarter in a row with organic growth of more than 30pct. while Terminals presented its best quarter ever.” Contact persons: Head of Investor Relations, Sarah Spray, tel. +45 3147 4170 Head of External...

Continue reading

Invitation to Tallinna Sadam Investor Conference Webinar for the results of Q1 2022

AS Tallinna Sadam invites all the stakeholders to join its investor conference webinar, introducing the results for Q1 2022. The webinar is scheduled for 10 May 2022 at 11.00 am Estonian time (GMT+3) and will be held in English on Microsoft Teams platform. The chairman of the management board Valdo Kalm and member of the management board / CFO Andrus Ait will be presenting the results and answering the questions. The questions will be answered after the presentation. Due to limited webinar time, we encourage participants to send their questions beforehand to e-mail: investor@ts.ee. To join the webinar, please click here. Please see the attached webinar invitation file to add the event to your calendar. The recording of the webinar will be available at the company’s web page: https://www.ts.ee/en/. Tallinna Sadam is one of the largest cargo-...

Continue reading

Maisons du Monde First Quarter 2022

PRESS RELEASE MAISONS DU MONDE FIRST QUARTER 2022:Sales in line with expectationsGrowth exceeding pre-pandemic performance at all levelsFirst quarter sales: EUR 313 million (-1.3% yoy; -4.0% LFL1; +15% vs Q1 2019)Gross merchandise volume2 (GMV): EUR 329 million (stable yoy; +21% vs Q1 2019)Online sales down 13% vs Q1 2021 high comparison base, up a strong 46% vs Q1 2019Marketplace GMV +43% yoyStore sales up 6% yoy, +5% vs Q1 2019 FY 2022 guidance confirmed, assuming no further deterioration of macro-economic and supply chain conditionsNANTES – 4 May 2022, 07:00 CEST – Maisons du Monde (Euronext Paris: MDM; ISIN: FR0013153541), a European leader in affordable and inspirational home and living, today publishes the Group’s sales for the first quarter of 2022. Julie Walbaum, Chief Executive Officer of Maisons du Monde,...

Continue reading

Compagnie Financière Tradition: Adjusted revenue for Q1 2022 up 3.8% at constant exchange rates to CHF 268.7m

  Ad hoc announcement pursuant to Article 53 of the Six ExchangeRegulation Listing Rules    Lausanne, 4 May 2022Q1 2022: adjusted revenue up 3.8% at constant exchange rates to CHF 268.7m The average level of activity for the first quarter showed an increase compared to the same period last year. Compagnie Financière Tradition reported consolidated revenue of CHF 247.7m in the first quarter 2022 compared with CHF 238.6m in same period in 2021, up 3.8% at current exchange rates. At constant exchange rates, consolidated revenue presented an increase of 3.7%. For the same period, the Group’s consolidated adjusted* revenue was CHF 268.7m compared with CHF 259.2m in 2021, an increase of 3.8% at constant exchange rates. The adjusted revenue from interdealer broking business (IDB) was up 3.6% at constant exchange...

Continue reading

Arcadis Trading Update Q1 2022

Continued strong organic revenue and record backlogStrong order intake inclusive of projects in energy transition, environmental restoration and new mobility, underpinning the strategy Continued client demand for sustainable solutions and advisory, resulting in net revenue of €688 million and organic net revenue growth of 5.6%1) Record backlog at €2.3 billion. Organic year-on-year backlog growth of 7.6%1) Operating EBITA margin improved to 9.4% (Q1’21: 9.2%) Net Working Capital of 12.9% (Q1’21: 15.3%) and DSO of 70 days (Q1’21: 78 days)Amsterdam, 4 May 2022 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, sees a continued growing client demand across its Global Business Areas (GBAs), resulting in an organic net revenue growth of 5.6%, and an organic backlog growth...

Continue reading

argenx to Present at BofA Securities 2022 Healthcare Conference

May 4, 2022 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022 at 10:40 a.m. P.T. in Las Vegas, NV. A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 90 days following the presentation. About argenx argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program...

Continue reading

Press release Biocartis Group NV: New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla™ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Compared to Routine Methods

PRESS RELEASE: 4 May 2022, 07:00 CEST New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla™ GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Compared to Routine MethodsTherapeutically actionable gene fusions drive approximately 10% of non-small-cell lung cancers1 Current molecular methods including Next Generation Sequencing (NGS) are complex with long turnaround times Study2 demonstrates the Idylla™ GeneFusion Assay (RUO3) enables more rapid screening of targetable fusions compared to routine methodsMechelen, Belgium, 4 May 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the publication of a new study in the Journal of Molecular Diagnostics on the Idylla™ GeneFusion Assay (RUO) for rapid detection...

Continue reading

Solvay secures sole ownership of its Green River, Wyoming natural soda ash operation

Solvay secures sole ownership of its Green River, Wyoming natural soda ash operation Brussels, May 4, 2022 – Solvay today announces the acquisition of the 20% minority stake of AGC in the Soda Ash JV operated in Green River, WY, USA, building on its leadership position in trona-based soda ash production. Solvay is a global leader in soda ash, with nine major soda ash and bicarbonate plants, of which six are located in Europe, two in the US and one in Asia. Solvay and AGC formed the Solvay Soda Ash Joint Venture (SSAJV) back in 1992. The facility, operated by Solvay, produces soda ash and sodium bicarbonate from trona, a naturally occurring mineral to serve the glass, chemicals, detergents and food industries, among others. “The acquisition of AGC’s stake in the JV simplifies our portfolio and is an attractive opportunity to enhance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.